ALESSE, EDOARDO
 Distribuzione geografica
Continente #
NA - Nord America 10.207
EU - Europa 6.273
AS - Asia 5.681
SA - Sud America 614
AF - Africa 69
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 16
Totale 22.879
Nazione #
US - Stati Uniti d'America 10.054
SG - Singapore 2.346
CN - Cina 1.266
IE - Irlanda 1.229
RU - Federazione Russa 1.153
IT - Italia 761
TR - Turchia 738
DE - Germania 672
SE - Svezia 631
BR - Brasile 533
FR - Francia 498
HK - Hong Kong 464
VN - Vietnam 461
GB - Regno Unito 435
UA - Ucraina 358
FI - Finlandia 252
IN - India 140
CA - Canada 79
BD - Bangladesh 60
CZ - Repubblica Ceca 56
JP - Giappone 53
MX - Messico 46
BE - Belgio 39
NL - Olanda 35
PL - Polonia 33
ES - Italia 32
ZA - Sudafrica 25
AR - Argentina 23
IQ - Iraq 20
AT - Austria 14
EU - Europa 14
PK - Pakistan 13
EC - Ecuador 12
ID - Indonesia 12
TN - Tunisia 12
AU - Australia 11
IL - Israele 11
SA - Arabia Saudita 11
CH - Svizzera 10
JM - Giamaica 9
KR - Corea 9
MY - Malesia 9
PH - Filippine 9
PY - Paraguay 9
RO - Romania 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
KE - Kenya 8
LT - Lituania 8
NZ - Nuova Zelanda 8
VE - Venezuela 8
CL - Cile 7
CO - Colombia 7
GR - Grecia 7
PT - Portogallo 7
DZ - Algeria 6
JO - Giordania 6
NP - Nepal 6
AZ - Azerbaigian 5
BO - Bolivia 4
DK - Danimarca 4
EG - Egitto 4
HU - Ungheria 4
IR - Iran 4
KZ - Kazakistan 4
PE - Perù 4
UY - Uruguay 4
AL - Albania 3
BY - Bielorussia 3
CR - Costa Rica 3
GT - Guatemala 3
LB - Libano 3
MA - Marocco 3
NO - Norvegia 3
PA - Panama 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SN - Senegal 3
TH - Thailandia 3
BG - Bulgaria 2
BN - Brunei Darussalam 2
GY - Guiana 2
HR - Croazia 2
MD - Moldavia 2
MK - Macedonia 2
NI - Nicaragua 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BZ - Belize 1
CG - Congo 1
CM - Camerun 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
GF - Guiana Francese 1
GH - Ghana 1
GI - Gibilterra 1
HN - Honduras 1
JE - Jersey 1
KW - Kuwait 1
Totale 22.863
Città #
Singapore 1.389
Jacksonville 1.369
Chandler 1.246
Dublin 1.223
San Jose 991
Dallas 935
Ashburn 544
Boardman 508
Santa Clara 479
Hong Kong 456
Izmir 344
Council Bluffs 298
Nanjing 276
San Mateo 237
New York 231
Wilmington 206
Moscow 196
The Dalles 194
Princeton 182
Lawrence 180
Beijing 170
Ann Arbor 150
Ho Chi Minh City 136
Lauterbourg 134
Los Angeles 120
Munich 110
Hanoi 108
L'aquila 99
L’Aquila 83
Milan 82
Woodbridge 81
Nanchang 77
Bremen 69
Shenyang 64
Verona 63
Rome 58
São Paulo 58
Helsinki 57
Seattle 55
Aquila 52
Hefei 52
Tokyo 51
Brno 50
Tianjin 50
Hebei 45
Des Moines 43
Mountain View 43
Orem 43
Kunming 42
Jiaxing 40
Brussels 38
Shanghai 38
Dearborn 36
Frankfurt am Main 33
Dong Ket 32
London 30
Warsaw 30
Atlanta 28
Changsha 28
Columbus 28
Montreal 28
Chennai 26
Houston 26
Da Nang 24
Jinan 24
San Francisco 24
Brooklyn 23
Denver 23
Johannesburg 21
Phoenix 21
Haiphong 20
Norwalk 20
Zhengzhou 20
Chicago 18
Manchester 18
Ningbo 18
Poplar 18
Turku 18
Kitzingen 17
Berlin 16
Mexico City 16
Amsterdam 15
Düsseldorf 15
Guangzhou 15
Nuremberg 15
Querétaro 15
Casoria 14
Philadelphia 14
Stockholm 14
Toronto 14
Falkenstein 13
Grafing 13
Lappeenranta 13
Pescara 13
Taizhou 13
Boston 11
Charlotte 11
Hangzhou 11
Pune 11
Belo Horizonte 10
Totale 14.779
Nome #
The prevalent KRAS exon 2 c.35 G > A mutation in metastatic colorectal cancer patients: a biomarker of worse prognosis and potential benefit of bevacizumab-containing intensive regimens? 199
new bioinformatics approach to identify target genes for dysregulated micrornas in a chemically-induced hepatocarcinoma mouse model 184
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 182
KRAS and Two Rare PI3KCA Mutations Coexisting in a Metastatic Colorectal Cancer Patient With Aggressive and Resistant Disease. 180
GADD45β loss ablates innate immunosuppression in cancer 180
Influence of L-carnitine on CD95 cross-linking-induced apoptosis and ceramide generation in human cell lines: Correlation with its effects on purified acidic and neutral sphingomyelinases in vitro 178
Bioinformatics approach to predict target genes for dysregulated microRNAs in hepatocellular carcinoma: Study on a chemically-induced HCC mouse model 176
EFFECTS OF SAFFRON ON HEPATOCARCINOGENESIS PROCESS: A STUDY ON A MOUSE MODEL 172
Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations. 171
Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis. 168
Therapeutic Use of MicroRNAs in Cancer 167
mir-182 dysregulation in a diet-induced NAFLD-NASH-hepatocellular carcinoma mouse model 166
Concurrent RAS and RAS/BRAF V600E variants in colorectal cancer: more frequent than expected? 162
Ruolo del gene oncosoppressore KCTD11REN(KCTD11) nel carcinoma prostatico umano. 160
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 158
Targeting the NF-κB pathway in prostate cancer: a promising therapeutic approach? 157
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 157
Cadmium inhibits spontaneous (NK), antibody-mediated (ADCC) and IL-2-stimulated cytotoxic functions of natural killer cells. 155
MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice 155
MicroRNAs Expression in Response to rhNGF in Epithelial Corneal Cells: Focus on Neurotrophin Signaling Pathway 155
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. 154
Angiotensin II inhibits endothelial cell motility through an AT1-dependent oxidant-sensitive decrement of nitric oxide availability 154
Next-generation sequencing: Recent applications to the analysis of colorectal cancer 152
Effect of calcium ionophore (A23187) on the production of thromboxane B2 in human polymorphonuclear cells in vitro 152
Emerging role of isomirs in cancer: State of the art and recent advances 152
New schedule of bevacizumab/paclitaxel as first-line therapy for metastatic HER2-negative breast cancer in a real-life setting 151
A ROLE FOR CA-2+ IN THE EFFECT OF VERY LOW-FREQUENCY ELECTROMAGNETIC-FIELD ON THE BLASTOGENESIS OF HUMAN-LYMPHOCYTES 149
Development of hepatocellular cancer induced by long term low fat-high carbohydrate diet in a nafld/nash mouse model 148
Combined antiviral therapy reduces HIV-1 plasma load and improves CD4 counts but does not intefere with ongoing lymphocytes apoptosis 147
MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression 146
Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma 145
development of hepatocellular cancer in a murine model of nonalcoholic steatohepatitis induced by use of low-fat/high carbohydrate diet 145
Low Radiation Environment Switches the Overgrowth-Induced Cell Apoptosis Toward Autophagy 145
ANALISI DEL miRNoma NELL’EPATOCARCINOMA INDOTTO DA DIETILNITROSAMINA 144
Cancer secretome and inflammation: The bright and the dark sides of NF-kB 144
L-carnitine reduces lymphocyte apoptosis and oxidant stress in HIV-1-infected subjects treated with zidovudine and didanosine 143
Effect of L-carnitine treatment in vivo on apoptosis and ceramide generation in peripheral blood lymphocytes from AIDS patients 142
two simulteneous and very uncommom pi3kca mutations in a liver metastasis from colorectal cancer patient with aggressive and resistant disease 141
Effect of the association of caffeine-indomethacin on the production of prostacyclin in the rat stomach 140
Effects of Reduced Natural Background Radiation on Drosophila melanogaster Growth and Development as Revealed by the FLYINGLOW Program 140
Molecular pathogenesis of bone metastases in breast cancer: Proven and emerging therapeutic targets. 139
Angiotensin II stimulates intercellular adhesion molecule-1(ICAM1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo 138
Circulating micrornas as prognostic and therapeutic biomarkers in breast cancer molecular subtypes 138
Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status. 137
Serum biomarkers identification by mass spectrometry in high-mortality tumors. 136
2-Aminopurine unravels a role for pRB in the regulation of gene expression by transforming growth factor beta 135
The effect of low-frequency sinusoidal pulse electromagnetic fields on human lymphocytes stimulated with mitogenic lectins. Preliminary results] 134
Riduzione del granuloma pouch dopo trattamento con Indometacina e Diflunisal e loro effetti collaterali sulla mucosa gastrica 133
NF-κB: A Druggable Target in Acute Myeloid Leukemia 132
Ultrasound-based method for the identification of novel microrna biomarkers in prostate cancer 132
Immunohistochemical Analysis of Expression, Phosphorylation, and Nuclear Translocation of NF-κB Proteins in Human Tissues 132
The N-terminal domain of the bone protein PRoline/arginine-rich End Leucine-rich repeat Protein (PRELP) impairs osteoclast formation by a new mechanism inhibiting NF-kappaB signaling 131
The Role of Circulating MicroRNAs as Biomarkers in NAFLD 131
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis 130
The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis 128
Enhanced thromboxane synthesis ans vacuolization in human polymorphonuclear leukocytes induced by human lumphokine containing supernatants 127
Acetyl-L-carnitine administration increases insulin-like growth factor 1 levels in asymptomatic HIV-1-infected subjects: correlation with its suppressive effect on lymphocyte apoptosis and ceramide generation 127
Effect of salicylates on lymphocyte blastogenesis in vitro: association with other non-steroid anti-inflammatory drugs. 127
crosstalk between nf-kb and shh pathways in prostate cancer 127
Worse prognosis of KRAS c.35 G > A mutant metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx). 127
Interaction of Diflunisal or Sodium Salicylate with aspirin or Indomethacin in prostacyclin release by gastric mucosa 127
Effect of L-carnitine on human immunodeficiency virus-1 infection-associated apoptosis: a pilot study 126
Effetti di campi magnetici pulsati a bassa frequenza ELF-EMF sulla mitogenesi di linfociti umani normali. 126
the role of kctd11 tumor suppressor gene in prostate cancer 126
Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pitutuitary adenomas: pathological and clinical implications 124
Reduced ulcerogenic effect after treatment with indomethacin combined with diflunisal in rats. 124
SENESCENT BONE MARROW DERIVED MESENCHYMAL STEM CELLS (MSC) ARE PRONE TO RECOVER DURING SSC 124
Age-associated changes in mouse oocytes during postovulatory in vitro culture: possible role for meiotic kinases and survival factor BCL2 124
A KRAS and dual concomitant PI3KCA mutations in a metastatic colorectal cancer patient with aggressive and resistant disease 123
Prognostic relevance of PIK3CA mutations in breast cancer patients treated with primary dose-dense epirubicin/cyclophosphamide -> dose-dense docetaxel 123
In vivo cadmium tratment alters natural killer activity and large granular lymphocyte number in the rat 122
Influence of L-Carnitine on CD95 cross-linking induced apoptosis and ceramide generation in human cell lines: correlation with its effects on purified acidic and neutral sphingomyelinase in vitro 122
Effect of L-carnitine treatment in vivo on apoptosis and ceramide generation by peripheral blood lymphocytes from AIDS patients. 122
KCTD11 tumor suppressor gene expression is reduced in prostate adenocarcinoma 122
Action of some salicylates associated with other non-steroidal anti-inflammatory drugs on the release of prostacyclin from the gastric mucosa of the rat 122
MIRNOME ANALYSIS IN THE PATHOGENESIS OF HEPATOCARCINOMA 121
Molecular Mechanisms Underpinning Immunometabolic Reprogramming: How the Wind Changes during Cancer Progression 120
Synergistic activation of natural-killer activity by human recombinant interferon-alpha or interferon-gamma and indomethacin. 120
Analisi del miRNoma nell’epatocarcinogenesi indotta da dietilnotrosamina. 120
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 120
The influence of levamisole in vitro on lymphocytes from an immunodeficient patient 120
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 120
Classification of tumor types using XGBoost machine learning model: a vector space transformation of genomic alterations 119
Biochemical Methods to Analyze the Subcellular Localization of NF-κB Proteins Using Cell Fractionation 119
Two familial giant pituitary adenomas associated with overweight: clinical, morphological and genetic features 118
Combined antiviral therapy reduces HIV-1 plasma load and improves CD4 counts but does not interfere with ongoing lymphocyte apoptosis 118
The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages. 118
Stimulatory effect of hr tumor necrosis factor on TxB2 release by polymorphonuclears and macrophages. 117
The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering 117
Apoptosis or programmed cell death 116
Prognostic relevance of KRAS genotype and the prevalent C.35 G > a mutation in metastatic colorectal cancer (MCRC) patients fitting for intensive FIr-B/FOx triplet chemotherapy plus bevacizumab 116
Biotech on the Rise: The Treatment of Psoriasis with Biological Drugs 116
Endotoxin-induced TxB2 release by polymorphonuclears and macrophages. 115
Interleukin-2 (IL-2) and 13-cis retinoic acid (RA) decrease vascular endothelial growth factor (VEGF) and prolong clinical benefit in patients with advanced solid tumors showing a partial response (PR) or stable disease (SD) to chemotherapy. J Clin Oncol 2005: 2, 27s (supplement). 115
Regolazione trascrizionale ed epigenetica del gene oncosoppressore KCTD11REN. 115
Targeting costimulatory molecules to improve antitumor immunity. 115
Basal cell carcinoma and inflammation: role of the Gadd45b gene 115
Life, death, and autophagy in cancer: NF-κB turns up everywhere 115
Takotsubo Syndrome during Pertuzumab and Trastuzumab Therapy for HER2-Positive Metastatic Breast Cancer 115
Characterization and biologic role of REN, a novel gene involved in neural cell differentiation 114
Totale 13.748
Categoria #
all - tutte 94.842
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.842


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.283 73 119 258 92 77 25 14 71 73 70 71 340
2022/20233.579 236 201 56 400 393 378 4 199 1.538 20 106 48
2023/2024882 127 44 35 125 64 208 8 80 3 29 31 128
2024/20253.617 115 96 397 144 450 298 428 332 716 154 266 221
2025/20267.578 336 709 634 1.026 694 650 1.217 247 583 898 430 154
2026/2027121 121 0 0 0 0 0 0 0 0 0 0 0
Totale 23.274